Compare XERS & PXED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | PXED |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2021 | N/A |
| Metric | XERS | PXED |
|---|---|---|
| Price | $6.17 | $30.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $10.83 | ★ $44.29 |
| AVG Volume (30 Days) | ★ 1.6M | 71.6K |
| Earning Date | 05-07-2026 | 04-07-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $34.37 | $3.85 |
| Revenue Next Year | $22.86 | $4.49 |
| P/E Ratio | $638.48 | ★ $11.20 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.30 | $23.52 |
| 52 Week High | $10.08 | $38.19 |
| Indicator | XERS | PXED |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 53.45 |
| Support Level | $5.79 | $28.40 |
| Resistance Level | $6.41 | $30.85 |
| Average True Range (ATR) | 0.32 | 1.37 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 28.51 | 57.47 |
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.